Evidence map›Paper›PMID 29872310›Full record

ArticleOncoTargets and therapy2018

Resveratrol inhibits the proliferation of A549 cells by inhibiting the expression of

Xia Li, Fang Li, Fangfang Wang, Jinfeng Li, Cunzhi Lin, Jianxin Du

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Anti-Inflammatory Properties of Resveratrol.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Natural Compounds for Preventing Age-Related Diseases and Cancers.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Anti-Inflammatory Action and Mechanisms of Resveratrol.Molecules (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xia LiRespiratory Department of Internal Medicine, Rizhao People's Hospital of Shandong Province, Rizhao, Shandong, 276800, China.
Fang LiRespiratory Department of Internal Medicine, Rizhao People's Hospital of Shandong Province, Rizhao, Shandong, 276800, China.
Fangfang WangPulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China.
Jinfeng LiPulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China.
Cunzhi LinPulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China.
Jianxin DuPulmonary Department, Affiliated Hospital of QingDao University, Qingdao, Shandong, 266003, China.
Qingdao University · CNPeople’s Hospital of Rizhao · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim was to investigate resveratrol effects on A549 cells proliferation.

methodsA total of 104 lung adenocarcinoma tissues and nontumor tissues were collected. BEAS-2B cells were cultured in RPMI 1640 medium (group A). A549 cells were treated with RPMI 1640 medium containing different resveratrol concentrations. A549 cells were transfected and grouped as follows: blank group, siRNA-negative control group, siRNA-COX-2 group and resveratrol + siRNA-COX-2 group. qRT-PCR and Western blot were conducted to detect

resultsThe relative expression of

conclusionResveratrol inhibits A549 cells proliferation by inhibiting

Indexed as

A549 cellCOX-2 expressionproliferationresveratrol

Identifiers

PMID29872310
PMCPMC5973427
OpenAlexW2803468468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.